We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
- Authors
Owusu-Agyei, Seth; Asante, Kwaku Poku; Owusu, Ruth; Adjuik, Martin; Amenga-Etego, Stephen; Dosoo, David Kwame; Gyapong, John; Greenwood, Brian; Chandramohan, Daniel
- Abstract
Artesunate+amodiaquine (AS+AQ) and artemether-lumefantrine (AL) are now the most frequently recommended first line treatments for uncomplicated malaria in Africa. Artesunate+chlorproguanil-dapsone (AS+CD) was a potential alternative for treatment of uncomplicated malaria. A comparison of the efficacy and safety of these three drug combinations was necessary to make evidence based drug treatment policies.
- Publication
PloS one, 2008, Vol 3, Issue 6, pe2530
- ISSN
1932-6203
- Publication type
Journal Article
- DOI
10.1371/journal.pone.0002530